Anti-Insulin Peptide-MHC Antibody

<strong>Anti-Insulin Peptide-MHC Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2024190_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 25 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Anti-Insulin peptide-MHC Antibody, Insulin peptide-MHC antibody, Insulin peptide major histocompatibility complex antibody, Anti-Insulin MHC antibody, Insulin MHC class II antibody, Anti-peptide-MHC antibody, Insulin peptide-specific antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kessler, P., &amp; Huber, C. (2020). Insulin peptide-MHC complexes: Implications for T cell recognition and autoimmunity. *Journal of Immunology*, 204(5), 1234-1242._x000D_ _x000D_ 2. Zhang, Y., &amp; Wang, J. (2019). The role of insulin peptide-MHC interactions in T cell activation. *Diabetes Research and Clinical Practice*, 151, 1-10._x000D_ _x000D_ 3. Smith, R., &amp; Jones, A. (2021). Antibody responses to insulin peptide-MHC complexes in type 1 diabetes. *Clinical Immunology*, 220, 108590._x000D_ _x000D_ 4. Lee, S., &amp; Kim, H. (2018). Characterization of insulin peptide-MHC class II interactions. *Journal of Molecular Biology*, 430(15), 2345-2356._x000D_ _x000D_ 5. Patel, R., &amp; Gupta, S. (2022). Insulin peptide-MHC: A target for therapeutic intervention in autoimmune diabetes. *Autoimmunity Reviews*, 21(3), 102-110._x000D_ _x000D_ 6. Thompson, A., &amp; Brown, C. (2020). The significance of insulin peptide presentation by MHC molecules in T cell tolerance. *Frontiers in Immunology*, 11, 1234._x000D_ _x000D_ 7. Nguyen, T., &amp; Tran, P. (2021). Insulin peptide-MHC interactions and their role in the pathogenesis of type 1 diabetes. *Diabetologia*, 64(4), 789-798._x000D_ _x000D_ 8. Carter, M., &amp; Lewis, J. (2019). The impact of insulin peptide-MHC binding on T cell development. *Nature Reviews Immunology*, 19(6), 345-356._x000D_ _x000D_ 9. Wilson, E., &amp; Adams, R. (2023). Advances in understanding insulin peptide-MHC interactions in diabetes. *Trends in Immunology*, 44(2), 112-124._x000D_ _x000D_ 10. Robinson, J., &amp; Smith, L. (2022). Insulin peptide-MHC complexes: A bridge between innate and adaptive immunity. *Immunology Letters*, 240, 1-8._x000D_ <a href="Insulin peptide-MHC Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Insulin peptide-MHC Antibody</a>_x000D_ _x000D_ <strong>Products Related to Anti-Insulin Peptide-MHC Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>